Evaluation of Quality of Life in Crohn’s Disease and Ulcerative Colitis: What Is Health-Related Quality of Life?



Fig. 25.1
Conceptual model of variables influencing quality of life in inflammatory bowel disease (reprinted from ref. [16] with permission from John Wiley & Sons, Inc.)



While most studies of HRQoL in the literature assess adult patients with IBD, several validated and reliable HRQoL questionnaires have been developed for pediatric IBD (P-IBD) patients in recent decades [1921]. Measuring HRQoL in pediatric patients is challenging when compared to adult patients, as both the age-specific natural development and “life-concerns”—which differ significantly during childhood and adolescence [22, 23]—influence a patient’s perception of HRQoL. Furthermore, a child may be unable (e.g., children <5 years old) [24] or unwilling to respond to questions. To overcome this challenge a parent-proxy concept is used where the parents answer questions on behalf of the child. Reviews examining the concordance between child self-reported and parent-proxy-reported HRQoL have shown that the best concordance concerns physical (objective) conditions while the least concordance relates to emotional and social items (subjective) [25]. However, parent-proxy answers for children with chronic diseases had a higher concordance than with those for healthy children. P-IBD patients are rarely younger than 5 years at diagnosis [26], nevertheless these patients often present with more severe or extensive disease [27], thereby underscoring the need to accurately measure HRQoL.

Clinicians and policymakers are increasingly cognizant of the importance of measuring HRQoL to inform patient management and policy decisions [28]. Patient-reported outcomes (PROs) capture the patient’s illness experience in a structured format and may help physicians better understand symptoms from the patient’s perspective [29]. PROs measure any aspect of health directly reported by the patient (e.g., physical, emotional, or social symptoms) and may help to direct care and improve clinical outcomes [30]. The ultimate PRO is improvement in HRQoL. In the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) guidelines [31, 32] for new drugs in IBD-validated HRQoL measurements, such as the inflammatory bowel disease questionnaire (IBDQ), are part of the secondary endpoint section among other considerations such as steroid sparing effect, treatment of abscess, endoscopic remission, and treatment of obstruction. Currently, the FDA is moving away from using disease activity indices as clinical trial endpoints and towards PROs when assessing the patient’s experience of symptoms and objective measures of disease [33]. Recently, the first professorship in PROs has been established in Denmark [34].



Quality of Life Indices and Questionnaires


Several different instruments exist for the assessment of HRQoL in IBD, as described in Table 25.1. Disease-specific questionnaires for HRQoL—derived from, and validated in, the relevant disease groups—are the most sensitive indicators of change over time or with treatment. Generic instruments, on the other hand, are used to show similarities or differences among groups or populations; however, they may not be sensitive to changes over time or subsequently to treatment in groups of patients with specific diseases [35].


Table 25.1
Overview of disease-specific quality of life and generic rating systems in IBD






















































































































































































































Quality of life

Items

Domains

Level (range)

Disease specific

Inflammatory Bowel disease Questionnaire (IBDQ) [36]

32

4

Above 170 (32–224)

10

Bowel symptoms

5

Systemic symptoms

5

Social function

12

Emotional function

Short Inflammatory Bowel disease Questionnaire (sib) [38]

10

4

Above 50 good (10–70)

3

Bowel symptoms

2

Systemic symptoms

2

Social function

3

Emotional function

Inflammatory Bowel disease Questionnaire outpatients [42]

36

5

(36–252)
 
Systemic symptoms
 
Bowel symptoms
 
Functional impairment
 
Social impairment
 
Emotional function

Short Health Scale (SHS) [44, 45]

100-mm VAS

4

Less than 25 mm (0–400 mm)
 
Symptoms
 
Functional status
 
Worry
 
General well-being

Rating Form of IBD Patient Concern (RFIPC) [49]

100-mm VAS

25

0 mm represents “not at all”

IMPACT III

Age 9–17 [22, 57]

35

7

3

7

12

3

3

6

Bowel symptoms

Systemic symptoms

Emotional functioning

Social functioning

Body image

Treatment/interventions

(35–175)

Generic

Short Form 36 (SF-36) [62]

36

8

(0, worst–100, best)

10

Physical functioning

2

Social function

4

Role limitations due to physical problems

3

Role limitations due to emotional problems

4

Energy/vitality level

5

Mental health

2

Bodily pain

5

General health perception

1

Health transition over time

Short Form 12 (SF-12) [63]

12

8

(0, worst–100, best)

2

Physical functioning

1

Social function

2

Role limitations due to physical problems

2

Role limitations due to emotional problems

1

Vitality level

2

Mental health

1

Bodily pain

1

General health perception

Psychological General well-being Index (PGWBI) [64]

22
 
Lower values—negative response (22–232)

5

Anxiety

3

Depressed mood

4

Positive well-being

3

Self-control

3

General health

4

Vitality

Pediatric Quality of Life Inventory™, Version 4.0 (PedsQL 4.0) [73]

Child: age 5–18

Parent-proxy: age 2–18

23

2

Linear transformation

(0–100)

8

Physical functioning subscale
 
Psychosocial health:

5

Emotional functioning

5

Social functioning

5

School functioning

TNO AZL

Child Quality Of Life (TACQOL)

Child: age 8–15

Parent-proxy: age 6–15 [76]

Preschool Quality of life

(TAPQOL)

Parent-proxy: age 1–5 [77]

56

7

0–32 in each scale

(0–224)

Linear transformation

(0–100)

8

8

8

8

8

8

8

Physical complaints

Motor functioning

Autonomous functioning

Cognitive functioning

Social functioning

Positive moods

Negative moods

43

4

3

3

3

3

4

3

7

4

3

3

3

21

Sleeping

Appetite

Lungs

Stomach

Skin

Motor functioning

Social functioning

Problem behavior

Communication

Anxiety

Positive mood

Liveliness


Disease-Specific Questionnaires



Inflammatory Bowel Disease Questionnaire (IBDQ)


In 1989, a group of doctors, together with sociologist Guyatt G at Hamilton University, Canada, developed and validated the disease-specific Inflammatory Bowel Disease Questionnaire (IBDQ ) [36, 37]. To date the questionnaire has been translated into 37 languages by forward and backward translation and can be purchased from Hamilton University (www.​mcmaster.​flintbox.​com).

The questionnaire comprises 32 items which measure the following broad domains: physical health, psychological health, social relationships, and environment. Responses are scored on a 7-point Likert scale, in which 7 corresponds to the highest level of functioning. Cumulative scoring above 170 points represents a good quality of life, with a possible range of 32–224. When compared with the general population, IBD patients have impaired quality of life in all four categories. The most frequent concerns of UC patients are having an ostomy bag, developing cancer, side effects, the uncertain nature of their disease, and the need for surgery. The most frequent concerns of CD patients are the uncertain nature of their disease, impaired energy level, side effects of medication, the need for surgery, and having an ostomy bag [35]. Surgical quality of life with inflammatory bowel disease has not been well examined and the IBDQ is not applicable to patients with stoma.

The short Inflammatory Bowel Disease Questionnaire (s-IBDQ) is a shorter version of the original instrument. It consists of ten items from the IBDQ covering all four dimensions where scoring above 50 points (range 10–70) indicates good quality of life [8] and may be more convenient for use in the office, for use in large research studies, or in clinical trials [38]. The s-IBDQ has recently been used for web-based treatment applications, where patients score their HRQoL at home using a validated eHealth tool [3941].

In 1992 a questionnaire to determine the subjective health status of patients with inflammatory bowel disease was developed and verified. To examine the quality of life in a group of “healthy” outpatients with IBD, the group from Edmonton, Canada developed a self-administered form of this questionnaire comprising 36 questions across five dimensions: systemic symptoms, bowel symptoms, functional impairment, social impairment, and emotional function. Scores ranging between 36 and 252 points are possible, with scores above 180 indicative of a good quality of life [42].


Short Health Scale (SHS)


The Short Health Scale (SHS) was developed in Sweden, initially designed as part of a network strategy to describe various aspects of the concept of health [43]. It is a self-administered questionnaire comprised of four items, each addressing a subjective health dimension: symptoms, functional status, worry, and general well-being (Tables 25.1 and 25.2). Responses are graded on a 100-mm visual analogue scale. The results, presented as an individual score for each of the four items, form a profile. The questions are open-ended so that patients can take into account any or all aspects of their life that they feel are important when completing the questionnaire [44]. The SHS correlates with the IBDQ and has been validated in adult Swedish and Norwegian IBD patients [4446], and has been evaluated in adult IBD patients in the UK [47] as well as Croatian pediatric-onset patients [48].


Table 25.2
Short Health Scale (SHS) with the four dimensions and four questions presented as 100 mm in VAS scale























1. How severe symptoms do you suffer from your bowel disease?

No symptoms __________________________________________ Very severe symptoms

2. Does your bowel disease interfere with your activities in daily life?

Not at all ________________________________________ Interferes to a very high degree

3. How much worry does your bowel disease cause?

No worry __________________________________________ Constant worry

4. What is your general sense of well-being?

Very well __________________________________________ Dreadful

Based on data from refs. [44, 45].


Rating Form of IBD Patient Concern (RFIPC)


The Rating Form of IBD Patient Concern (RFIPC) , a 25-item disease-specific questionnaire, rates worries and concerns of patients with IBD on a 100-mm VAS scale (range, 0–100 mm) [49]. Zero mm represents “not at all” and 100 “a great deal.” The sum score is the mean average of the scores across all 25 items. The RFIPC has been found to be reliable and valid [5053]; while it is not applicable to patients with stoma, it has been validated in patients with pouch after proctocolectomy [54].


IMPACT


The most regularly used disease-specific HRQoL for P-IBD is IMPACT [55], which is also recommended by the pediatric committee of the European Crohn’s and Colitis Organization (P-ECCO) as a secondary outcome measure in clinical trials [56]. The IMPACT questionnaire originates in Canada and was developed after item-generated and item-reduction interviews with 82 P-IBD patients (8–17 years) [22]. To mirror the adult IBDQ, it was decided beforehand to arrive at a 33-item questionnaire in the item-reduction phase. Responses to each question are recorded on a 10 cm VAS (with increments of 0.7 cm, for comparison to the IBDQ score). The 33 items are divided according to six dimensions: bowel symptoms; body image; emotional functioning; social functioning; tests/treatments; and systemic symptoms. A higher score represents a better quality of life (with a range of 0–231).

IMPACT has been validated and found reliable in Canada [57]. It was further tested in Europe, among British and Dutch children, where it was found that some of the questions were inappropriate and/or too difficult to understand. Subsequently a simpler wording of the questionnaire was introduced and some of the questions were replaced, resulting in IMPACT II (35 items, VAS score, same six dimensions, score range of 0–245) [58]. IMPACT III consists of the same questions as IMPACT II, but with a 5-point Likert scale (score range of 35–175) instead of VAS [59]. IMPACT III has been validated and evaluated in children [58, 60] as well as in a parent-proxy setting, showing overall good concordance—except with regard to emotional functioning, where parents scored emotional functioning lower than did their children [61]. IMPACT III has been translated through cross-cultural adaptation into 40 languages [56].


Generic Questionnaires



Short Form-36 (SF-36)


The SF-36 is a generic questionnaire containing 36 items [62]. Thirty-five of the items are grouped into eight multi-item scales. The eight domains of the SF-36 are as follows: physical function (ten items); social function (two items); role limitations due to physical problems (four items); role limitations due to emotional problems (three items); energy/vitality (four items); mental health (five items); bodily pain (two items); and general health perception (five items). In addition, it contains a one-item measure of self-evaluated change in health status (health transition) over the previous year. For each question, a raw score is coded and transformed into a percentage, with 0 indicating the least favorable possible health status and 100 indicating the most favorable.

The 12-item Short Form Health Survey (SF-12) was developed for the Medical Outcomes Study (MOS), a multi-year study of patients with chronic conditions [63]. The resulting short-form survey instrument provides a solution to the problem faced by many investigators who must restrict survey length. It consists of 12 questions grouped into a physical and a mental component summary score (PCS and MCS) and eight multi-item scales. The instrument was designed to reduce respondent burden while achieving minimum standards of precision for purposes of group comparisons involving multiple health dimensions.


Psychological General Well-Being Index (PGWBI )


The Psychological General Well-Being Index (PGWBI) is a generic 22-item questionnaire measuring subjective feelings of well-being and distress [64]. Responses are graded on a 6-point Likert scale. Lower values correspond to more negative responses and higher values to more positive responses. The overall score is the summation of the item responses, ranging from 22–132. The questionnaire has been used alone and in combination with other generic and disease-specific questionnaires, both in general populations and in studies of chronic illness. The PGWBI has been translated and culturally adapted into at least 36 languages.


Pediatric Quality of Life Inventory (PedsQL)


PedsQL [65] is a regularly used generic HRQoL for assessing those with P-IBD [10, 48, 6672]. It is valid and reliable [7375] and exists in several languages [19]. The updated version, PedsQL 4.0 Generic Core Scales [73], consists of 23 items covering the following dimensions: (1) physical functioning, (2) emotional functioning, (3) social functioning, and (4) school functioning. The questionnaire consists of parallel versions, with child self-reported (ages 5–7, 8–12, and 13–18) and parent-proxy-reported (age 2–18) scores. The child self-reported and parent-reported versions are essentially identical but differ in the wording of the questions (i.e., first or third person, respectively). Furthermore, the school-related items differ depending on the age of the child. Answers are given on a 5-point (0–4) scale or a 3-point (0, 2, and 4) scale, expressed as corresponding faces to ease the process for the youngest patients (age 5–7). Items are reverse-scored and linearly transformed to a 0–100 scale divided by the number of items answered. Higher scores represent a better HRQoL. The score can be evaluated as a total HRQoL score and two summary scores: physical health (dimension 1) and psychosocial health (dimensions 2–4). A PedsQL family information form is used to collect demographic data and information about missing days of school and work (for the parents) caused by the child’s ill health.

Another generic HRQoL measure is the Netherlands Organization for Applied Scientific Research Academic Medical Centers (TNO AZL) Child Quality Of Life (TACQOL) and Preschool Children Quality of Life (TAPQOL) [76, 77]. TACQOL and TAPQOL have been used in Dutch P-IBD publications [14, 58, 78]; while other pediatric generic HRQoL questionnaires used in pediatric populations exist [19, 20], they appear less regularly in P-IBD publications.


Evaluation of QoL in IBD Patients


The role of extrinsic factors —the characteristics of the social surroundings (e.g., family, social network, QoC, social security, infrastructure, occupation, cultural, and religious values)—in patients’ perception of HRQoL is well studied in IBD. The significance of family and social support has been described in both adult and pediatric studies [71, 7984]. Regarding HRQoL among parents of children with IBD, scores decrease with worsening disease activity in the child [85].

The aforementioned European Collaborative Study on IBD (EC-IBD) was able to show that HRQoL is influenced by a variety of factors in the community setting [16, 86]. A moderate correlation between patient-reported IBD-related concerns and adverse national parameters has been found [52]. Ethnic and religious differences have also been put forward as predictors of HRQoL outcome in IBD [87, 88].

Intrinsic factors refer to mental and physical aspects of the respondent dependent of respectively (1) gender, age, personality, preference, life goals, coping strategy, experience, knowledge, education, psychiatric disorder and (2) comorbidity, disease severity and duration, complication, general physical health status.

Being female has, in the majority of studies of adult IBD patients, been associated with a poorer HRQoL in CD, in other diseases, and in the general population [8991]. However in P-IBD, results have shown no disparity in HRQoL among girls and boys [74, 78, 92, 93]. In some P-IBD studies, poorer HRQoL was associated with higher age (i.e., adolescents) [14, 15] while other studies showed no significant effect [74, 92]. While the elderly have a poorer generic HRQoL in general population health surveys, particularly regarding physical domains [89], in several studies on HRQoL in IBD age was shown to have little or no effect [3, 94, 95].

Personality traits, coping strategies and mental illness have been found to influence HRQoL in adult and pediatric IBD populations [93, 96101]. Furthermore, an individual’s ability to cope with ill-health can change over time. Health impairments may elicit a process of accommodation in which the internal standards, values, and conceptualization of subjective health evaluations are changed. This phenomenon, known as “response,” is an important factor in HRQoL over time and an important contributor to HRQoL outcome, possibly explaining improvements of HRQoL in the long term, and also counterintuitive findings of enhanced HRQoL in patients with severe disease [102]. Despite this phenomenon, and the widely described mitigating long-term disease course [103105], HRQoL seems not to be affected by disease duration in CD [2, 95, 99, 100, 106].

A higher educational level has been associated with better IBD-related HRQoL [49, 95], but specific IBD educational programs have not been shown to improve HRQoL in adult IBD patients [107, 108]. However, among P-IBD patients HRQoL was found to improve after attending a camp sponsored by the Crohn’s and Colitis Foundation of America, suggesting a normalizing of the chronic illness experience [109].

Low socioeconomic status and smoking have also been linked to a poorer HRQoL among those with CD [5, 110]. Disease activity and severity has in many studies been a strong predictor of adult and pediatric HRQoL in IBD [10, 14, 15, 98, 101, 111, 112], even though a disease phenotype (as classified by age at diagnosis, location, and behavior) was found to have no effect on HRQoL in a 2005 study by Casella’s [4]. Finally, comorbidity has been found to be detrimental to HRQoL, in both physical and mental terms, when assessing patients using IBD-specific instruments [3, 106].

In a comprehensive analysis of 22 studies of quality of life in CD [113], HRQoL was better in healthy controls and UC patients (except pre-colectomy ones) than in CD patients. Health-related quality of life was similar to, or worse than, that among those with a variety of other chronic medical conditions. Health-related quality of life was directly correlated with CD activity and was worse among those with active disease than among those in remission. In P-IBD studies, the HRQoL was comparable to that found in other chronic or acute illnesses, but worse than that among healthy children [10, 11]. Finally, HRQoL studies have found a high representation of depressive symptoms and disorders in P-IBD patients [82, 114116].

Health-related quality of life was found to improve for a short time after surgical resection [117]. In addition, active IBD had a negative impact on labor force participation [118] and relationship and sexual health [119]. In P-IBD, patients receiving an ideal J-pouch anal anastomosis were reported to be satisfied with the surgical procedure [120] and HRQoL scores were similar to those among healthy children [72, 121]. As such, physicians should not necessarily avoid surgery when striving for the most important goal of medical therapy, which is to make the patient well [122, 123].


Perspectives


Health-related quality of life is a useful metric when assessing the efficacy of medication in trials and has been validated in several different disease activity scoring systems. Short form questionnaires for disease-specific and generic HRQoL are recommended in the everyday clinical setting. The most established HRQoL measures described in the literature are the IBDQ (adult) and IMPACT III (pediatric). PROs are emerging as important endpoints in drug trials as treatment targets for IBD that in the future could be used in treat-to-target strategies in routine clinical practice.

In recent year’s eHealth , including self-management tools, has been introduced as an important “adjuvant” to medical therapy. This approach can improve adherence to medication among IBD patients [39], time in remission [39, 41], as well as HRQoL [39, 124] by involving patients in their own treatment and disease course. Two recent meta-analyses showed that distance management was able to decrease the number of clinic visits and improve HRQoL, adherence to therapies, knowledge about the disease, reduction of health care costs for IBD, and shorter time to remission [125, 126]. eHealth instruments in pediatric settings are currently under evaluation in Holland, the USA and Denmark [127129].

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 27, 2017 | Posted by in GASTROENTEROLOGY | Comments Off on Evaluation of Quality of Life in Crohn’s Disease and Ulcerative Colitis: What Is Health-Related Quality of Life?

Full access? Get Clinical Tree

Get Clinical Tree app for offline access